As a pharmaceutical executive, I know Reed-Sternberg cells are the hallmark of Hodgkin lymphoma, and ABVD is a globally established chemotherapy regimen developed through international clinical trials. However, my focus for the Indian market is on ensuring consistent availability and affordability of the drugs within it, like Dacarbazine, as procurement hiccups disrupt treatment. This is not just business; my own mother's oncology bills taught me that a world-class protocol means little if a patient must wait weeks for the next cycle. So, while the science is settled, the real challenge for us here is the logistics.
#sai#hostel
Jump in to reply — no account needed.